, Volume 34, Issue 4, pp 317–328 | Cite as

Disorders of the mononuclear phagocyte system. An analytical review

  • Gerhard Meuret
Zusammenfassender Bericht


Public Health Mononuclear Phagocyte Analytical Review Mononuclear Phagocyte System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Albrecht M.: „Gaucher“-Zellenbei chronisch myeloischer Leukämie.Blut 13, 169 (1966).Google Scholar
  2. 2.
    Alexander P., Evans R. & Grant C. K.: The interplay of lymphoid cells and macrophages in tumor immunity.Ann. Inst. Past. 122, 645 (1972).Google Scholar
  3. 3.
    Aster R. H. & Enright S. E.: A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.J. clin. Invest. 48, 1199 (1969).Google Scholar
  4. 4.
    Berendes H., Bridges R. A. & Good R. A.: A fatal granulomatosis in childhood: the clinical study of a new syndrome.Minn. Med. 40, 309 (1957).Google Scholar
  5. 5.
    Blume R. S. & Wolff S. M.: The Chediak-Higashi syndrome: Studies in four patients and a review of the literature.Medicine 51, 247 (1972).Google Scholar
  6. 6.
    Bodel P. & Atkins E.: Release of endogenous pyrogen by human monocytes.New Engl. J. Med. 276, 1002 (1967).Google Scholar
  7. 7.
    Boetcher D. A. & Leonard E. J.: Abnormal monocyte chemotactic response in cancer patients.J. nat. Cancer Inst. 52, 1091 (1974).Google Scholar
  8. 8.
    Boggs D. R. & Boggs S. S.: The pathogenesis of aplastic anemia: a defective pluripotent hematopoietic stem cell with inappropriate balance of differentiation and self-replication.Blood 48, 71 (1976).Google Scholar
  9. 9.
    Broun O. G., Jr.: Chronic erythromonocytic leukemia.Amer. J. Med. 47, 785 (1969).Google Scholar
  10. 10.
    Cannat A. & Seligmann M.: Immunological abnormalities in juvenile myelomoocytic leukemia.Brit. med. J. 1, 71 (1973).Google Scholar
  11. 11.
    Cederbaum S. D., Niwayama G., Stiehm E. R., Neerhout R. C., Ammann A. J. & Berman W., Jr.: Combined immunodeficiency presenting as the Letterer-Siwesyndrome.Pediatrics 85, 466 (1974).Google Scholar
  12. 12.
    Cline M. J. & Golde D. W.: A review and reevaluation of the histiocytic disorders.Amer. J. Med. 55, 49 (1973).Google Scholar
  13. 13.
    Cochrane C. G., Revak S. D., Wuepper K. D., Johnston A., Morrison D. C. & Ulevitch R.: Activation of Hageman factor and the kinin forming intrinsic clotting, and fibrinolytic systems. In: Raspe G. (Ed.): Avances in the Biosciences,12, 237 (1974).Google Scholar
  14. 14.
    Cohen S. & Ward P. A.: Lymphocyte-derived eosionophil chemotactic factor.J. exp. Med. 133, 133 (1971).Google Scholar
  15. 15.
    Cutting H. O. & Lang J. E.: Familial benign chronic neutropenia.Ann. intern. Med. 61, 876 (1964).Google Scholar
  16. 16.
    Dannenberg A. M., Jr.: Macrophages in inflammation and infection.New Engl. J. Med. 293, 489 (1975).Google Scholar
  17. 17.
    Davies P. & Allison A. C.: The macrophage as a secretory cell in chronic inflammation.Agents and Actions 6, 60 (1976).Google Scholar
  18. 18.
    Dosik H., Rosner F. & Sawitsky A.: Acquired lipoidosis: Gaucher-like cells and “blue cells” in chronic granulocytic leukemia.Sem. bemat. 9, 309 (1972).Google Scholar
  19. 19.
    Evans R.: Macrophages in syngeneic animal tumors.Transplantation 14, 468 (1972).Google Scholar
  20. 20.
    Evans R.: Macrophages and the tumor bearing host.Br. J. Cancer 28, 19 (1973).Google Scholar
  21. 21.
    Evans R. & Alexander P.: Mechanisms of immunologically specific killing of tumor cells by macrophages.Nature 236, 168 (1972).Google Scholar
  22. 22.
    Evans R. & Alexander P.: Mechanisms of extracellular killing of nucleated mammalian cells by macrophages. In: Nelson D. S. (Ed.): Immunobiology of the macrophage, p. 535, Academic Press 1976.Google Scholar
  23. 23.
    Furth van R., Langevoot H. L. & Schaberg A.: Mononuclear phagocytes in human pathology-proposal for an approach to improved classification. In: Furth van R. (Ed.): Mononuclear Phagocytes in Immunity, Infection, and Pathology. Blackwell 1975, p. 1.Google Scholar
  24. 24.
    Glass A. G. & Miller R. W.: U.S. mortality from Letterer-Siwe disease.Pediatrics 42, 364 (1968).Google Scholar
  25. 25.
    Golde D. W.: Disorders of mononuclear phagocyte proliferation, maturation and function.Clin. Haemat. 4, 705 (1975).Google Scholar
  26. 26.
    Golde D. W., Finlay T. N. & Cline M. J.: Production of colony-stimulating factor by hmuan macrophages.Lancet 2, 1397 (1972).Google Scholar
  27. 27.
    Gordon S., Todd J. & Cohn Z. A.: In vitro synthesis and secretion of lysozyme by mononuclear phagocytes.J. exp. Med. 139, 1228 (1974).Google Scholar
  28. 28.
    Gordon S., Unkeless J. C. & Cohn Z. A.: Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis. Evidence for a two stage process.J. exp. Med. 140, 995 (1974).Google Scholar
  29. 29.
    Hersh E. M., Mavligit G. M., Gutterman J. U. & Barsales P. B.: Mononuclear cell content of human solid tumorsMed. Pediat. Oncol. 21, 1 (1976).Google Scholar
  30. 30.
    Hitzig W. H.: Familiäre Neutropenie mit dominantem Erbgang und Hypergammaglobulinämie.Helv. med. Acta 26, 779 (1959).Google Scholar
  31. 31.
    Husby G., Hoagland P. M., Strickland R. G. & Williams R. C., Jr.: Tissue T and B cell infiltration of primary and metastatic cancer.J. clin. Invest. 57, 1471 (1976).Google Scholar
  32. 32.
    Kazmierowski J. A., Elin R. J., Reynolds H. Y., Durbin W. A. & Wolff S. M.: Chediak-Higashi syndrome: reversal of increased susceptibility to infection by bone marrow transplantation.Blood 47, 555 (1976).Google Scholar
  33. 33.
    Kostman R.: Infantile genetic agranulocytosis.Acta paediat. 45, Suppl. 105, 1 (1956).Google Scholar
  34. 34.
    Kyriakos M. & Kempson R. L.: Inflammatory fibrous histiocytoma. An aggressive and lethal lesion.Cancer 37, 1606 (1976).Google Scholar
  35. 35.
    Lahey M. E.: Histiocytosis X — comparison of three treatment regims.J. Pediatr. 87 II, 664 (1962).Google Scholar
  36. 36.
    Lampert F. & Lennert K.: Sinus histiocytosis with massive lymphadenopathy.Cancer 37, 783 (1976).Google Scholar
  37. 37.
    Lehrer R. I. & Cline M. J.: Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.J. clin. Invest. 48, 1478 (1969).Google Scholar
  38. 38.
    Leikin S., Puruganan G., Frankel A., Steerman R., Chandra R.: Immunologic parameters in histiocytosis X.Cancer 32, 796 (1973).Google Scholar
  39. 39.
    Lichtenstein L.: Histiocytosis X. Integration of eosinophilic granuloma of bone, “Letterer-Siwe disease,” and “Schüller-Christian disease” as related manifestations of a single nosologic entity.Arch. Path. 56, 84 (1953).Google Scholar
  40. 40.
    Lieberman P. H., Jones C. R., Dargeon H. W. K. & Begg C. F.: A reappraisal of eosinophilic granuloma of bone, Hand-Schüller-Christian Syndrome and Letterer-Siwe-Syndrome.Medicine 48, 375 (1969).Google Scholar
  41. 41.
    Lohmann-Mattes M. L.: Introduction of macrophage-mediated cytoxicity. In: Nelson D. S. (Ed.). Immunobiology of the macrophage, p. 464, Academic Press, 1976.Google Scholar
  42. 42.
    Lucaya Z.: Histiocytosis X.Amer. J. Dis. Child. 121, 289 (1971).Google Scholar
  43. 43.
    Mac Mahon H. E., Bedizel M. & Ellis C. A.: Familial erythrophagocytic lymphohistiocytosis,Pediatrics 32, 868 (1963).Google Scholar
  44. 44.
    Mergenhagen S. E., Wahl S. M., Wahl L. M., Horton J. E. & Raiz L. G.: The role of lymphocytes and macrophages in the destruction of bone and collagen.Ann. N. Y. Acad. Sci. 256, 132 (1975).Google Scholar
  45. 45.
    Metcalf D.: Regulation of granulocyte and monocyte-macrophage proliferation by colony stimulating factor (CSF): a review.Exp. Hemat. 1, 185 (1973).Google Scholar
  46. 46.
    Metcalf D. & Moore M. A. S.: In: Haematopoietic Cells. North Holland Publishing Comp., Amsterdam-London (1971).Google Scholar
  47. 47.
    Meuret G.: Unpublished observations.Google Scholar
  48. 48.
    Meuret G. & Fliedner T. M.: Neutrophil and monocyte kinetics in a case of cyclic neutropenia.Blood 44, 801 (1974).Google Scholar
  49. 49.
    Meuret G. & Hoffmann G.: Monocyte kinetic studies in normal and disease states.Brit. J. Haemat. 24, 275 (1973).Google Scholar
  50. 50.
    Meuret G., Bammert J. & Hoffmann G.: Kinetics of human monocytopoiesis.Blood 44, 801 (1974).Google Scholar
  51. 51.
    Meuret G., Schmitt E. & Hagedorn M.: Monocytopoiesis in chronic exzematous diseases, psoriasis vulgaris, and mycosis fungoides.J. Invest. Dermat. 66, 22 (1976).Google Scholar
  52. 52.
    Meuret G., Bundschu-Lay A., Senn H. J. & Huhn D.: Functional characteristics of chronic monocytic “leukemia.”Acta haemat. 52, 95 (1974).Google Scholar
  53. 53.
    Meuret G., Schmitt E., Senn H. J. & Hoffmann G.: Monozytopoese, Makrophagenumsatz bei entzündlichen und malignen Erkrankungen.Blut, Suppl. (in press).Google Scholar
  54. 54.
    Meuret G., Detel U., Kilz H. P., Senn H. J. & Lessen van H.: Human monocytopoiesis in acute and chronic inflammation.Acta haemat. 54, 328 (1975).Google Scholar
  55. 55.
    Miescher P. A. & Farquet J. J.: Chronic myelomonocytic leukemia in adults.Sem. in Hemat. 11, 129 (1974).Google Scholar
  56. 56.
    Morley J.: Prostaglandins and lymphokines in rheumatoid arthritis.Prostaglandins 8, 315 (1974).Google Scholar
  57. 57.
    Nadeau P. J., Ellis H. F. Jr., Harrison E. G. Jr. & Fontana R. S.: Primary pulmonary histiocytosis X.Dis. Chest. 37, 325 (1960).Google Scholar
  58. 58.
    Osserman E. F.: Clinical and biochemical studies of plasmacytic and monocytic dyscrasias and their interrelationships.Trans. Stud. Coll. Phycns. Philad. 36, 134 (1969).Google Scholar
  59. 59.
    Osserman E. F. & Lawlor D. P.: Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.J. exp. Med. 124, 921 (1966).Google Scholar
  60. 60.
    Pike B. & Robinson W. A.: Human bone marrow culture in agar gel.J. cell. Physiol. 76, 77 (1970).Google Scholar
  61. 61.
    Postlethwaite A. E. & Kang A. H.: Collagen- and collagen peptide-induced chemotaxis of human blood monocytes.J. exp. Med. 143, 1299 (1976).Google Scholar
  62. 62.
    Pretlow T. G.: Chronic monocytic dyscrasia culminating in acute leukemia.Amer. J. Med. 46, 130 (1969).Google Scholar
  63. 63.
    Pruszanski W. & Platts M. E.: Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia.J. clin. Invest. 49, 1694 (1970).Google Scholar
  64. 64.
    Ratnoff O. D.: Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response.Adv. Immun. 10, 145 (1969).Google Scholar
  65. 65.
    Richardson D. L., Pepper D. S. & Kay A. B.: Chemotaxis for human monocytes by fibrinogen-derived peptides.Brit. J. Haemat. 32, 507 (1976).Google Scholar
  66. 66.
    Root R. K., Rosenthal A. S. & Balestra D. J.: Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi syndrome leukocytes.J. clin. Invest. 51, 649 (1972).Google Scholar
  67. 67.
    Rosai J. & Dorfman R. F.: Sinus histiocytosis with massive lymphadenopathy — a pseudolymphomatous benign disorder.Cancer 30, 1174 (1972).Google Scholar
  68. 68.
    Ruddy S., Gigli I. & Austen K. F.: The complement system of man.New Engl. J. Med. 287, 489 (1972).Google Scholar
  69. 69.
    Ruddy S., Gigli I. & Austen K. F.: The complement system of man.New Engl. J. Med. 287, 545 (1972).Google Scholar
  70. 70.
    Ruscetti F. W. & Chervenick P. A.: Release of colony stimulating activity from thymus-derived lymphocytes.J. clin. Invest. 55, 520 (1975).Google Scholar
  71. 71.
    Ruscetti F. W., Cypess R. H. & Chervenick P. A.: Specific release of neutrophilic- and eosinophilic-stimulating factors from sensitized lymphocytes.Blood 47, 757 (1976).Google Scholar
  72. 72.
    Saarni M. T. & Linman J. W.: Myelomonocytic leukemia: disorderly proliferation of all marrow cells.Cancer 27, 1221 (1971).Google Scholar
  73. 73.
    Saarni M. T. & Linman J. W.: The hematologic syndrome preceding acute leukemia.Amer. J. Med. 55, 38 (1973).Google Scholar
  74. 74.
    Salmon S. E., Cline M. J., Schulz J. & Lehrer R. I.: Myeloperoxidase deficiency: a genetic leukocyte defect.New Engl. J. Med. 282, 250 (1970).Google Scholar
  75. 75.
    Sandberg A. A. & Hossfeld D. K.: Chromosomal abnormalities in human neoplasia.Ann. Rev. Med. 21, 379 (1970).Google Scholar
  76. 76.
    Schmalzl F.: Unreifzellige Monozytenleukämien.Blut 22, 157 (1972).Google Scholar
  77. 77.
    Schmalzl F., Huhn D., Asamer H., Abbrederis K. & Braunsteiner H.: Atypical (monomyelocytic) myelogenous leukemia.Acta haemat. 48, 72 (1972).Google Scholar
  78. 78.
    Schmitt E., Meuret G. & Stix L.: Monocyte recruitment in tuberculosis and sarcoidosis.Brit. J. Haemat. 35, 11 (1977).Google Scholar
  79. 79.
    Scott R. B. & Robb-Smith A. H. T.: Histiocyte medullary reticulosis.Lancet 237, 194 (1939).Google Scholar
  80. 80.
    Seshadri R. S., Brown E. J. & Zipursky A.: Leukemic reticuloendotheliosis. A failure of monocyte production.New Engl. J. Med. 295, 181 (1976).Google Scholar
  81. 81.
    Silverstein M. N. & Ellefson R. D.: The syndrome of the seablue histiocyte.Sem. Hemat. 9, 299 (1972).Google Scholar
  82. 82.
    Snyderman R. & Mergenhagen S. E.: Chemotaxis of macrophages. In: Nelson D. S. (Ed.).: Immunobiology of the macrophage. Academic Press, New York, San Francisco, London, p. 232 (1976).Google Scholar
  83. 83.
    Spector W. G. & Mariano M.: Macrophage behaviour in experimental granulomas. In: (Furth R. van, Ed.) Mononuclear Phagocytes in Immunity Infection, and Pathology. Blackwell, Oxford-Edinburgh, p. 927 (1975).Google Scholar
  84. 84.
    Stanley E. R., Cifone M., Heard P. M. & Defendi V.: Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor.J. exp. Med. 143, 631 (1976).Google Scholar
  85. 85.
    Twomey J. J., Douglass C. C. & Sharkey O., Jr.: The monocytopenia of aplastic anemia.Blood 41, 187 (1973).Google Scholar
  86. 86.
    Unkeless J. C., Gordon S. & Reich E.: Secretion of plasminogen activator by stimulated macrophages.J. exp. Med. 139, 834 (1974).Google Scholar
  87. 87.
    Wahl L. M., Wahl S. M., Mergenhagen S. E. & Martin R. R.: Collagenase production by lymphokine activated macrophages.Science 187, 261 (1975).Google Scholar
  88. 88.
    Warnke R. A., Kim H. & Dorman R. F.: Malignant histiocytosis (histiocytic medullary reticulosis).Cancer 35, 215 (1975).Google Scholar
  89. 89.
    Weiden P. L., Robinett B., Graham T. C., Adamson J. & Storb R.: Canine cyclic neutropenia: a stem cell defect.J. clin. Invest. 53, 950 (1974).Google Scholar

Copyright information

© Springer-Verlag 1977

Authors and Affiliations

  • Gerhard Meuret
    • 1
  1. 1.Department of Internal Medicine, Section of Hematology and OncologyKantonsspitalSt. Gallen

Personalised recommendations